The carotenoid lycopene differentially regulates phase I and II enzymes in dimethylbenz[a]anthracene-induced MCF-7 cells

Nutrition

Volumn 26, Issue 11-12, 2010, Pages 1181-1187

  Wang, Huan ^a   Leung, Lai K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; DIMETHYLBENZ[A]ANTHRACENE; ETHOXYRESORUFIN DEETHYLASE; LYCOPENE;

ARTICLE; BREAST CARCINOGENESIS; CANCER CELL; CARCINOGEN DNA INTERACTION; CELL CULTURE; CELL ISOLATION; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; FOOD INTAKE; GLUCURONIDATION; HUMAN; HUMAN CELL; MICROSOME; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CARCINOGENS; CAROTENOIDS; CELL LINE, TUMOR; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 ENZYME SYSTEM; DNA ADDUCTS; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCURONOSYLTRANSFERASE; HUMANS; KINETICS; METABOLIC DETOXICATION, PHASE I; METABOLIC DETOXICATION, PHASE II; MICROSOMES; RECOMBINANT PROTEINS; RESPONSE ELEMENTS; RNA, MESSENGER;

ANIMALIA;

EID: 77957763728     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.11.013     Document Type: Article

References (46)

1. Stahl W., Sies H. Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans. J Nutr 1992, 122:2161-2166.
2. Mortensen A., Skibsted L.H. Relative stability of carotenoid radical cations and homologue tocopheroxyl radicals. A real time kinetic study of antioxidant hierarchy. FEBS Lett 1997, 417:261-266.
3. Di Mascio P., Kaiser S., Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989, 274:532-538.
4. Rao A.V., Agarwal S. Role of antioxidant lycopene in cancer and heart disease. J Am Coll Nutr 2000, 19:563-569.
5. Rao A.V., Rao L.G. Carotenoids and human health. Pharmacol Res 2007, 55:207-216.
6. Sato R., Helzlsouer K.J., Alberg A.J., Hoffman S.C., Norkus E.P., Comstock G.W. Prospective study of carotenoids, tocopherols, and retinoid concentrations and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2002, 11:451-457.
7. Livny O., Kaplan I., Reifen R., Polak-Charcon S., Madar Z., Schwartz B. Lycopene inhibits proliferation and enhances gap-junction communication of KB-1 human oral tumor cells. J Nutr 2002, 132:3754-3759.
8. Lewtas J. Air pollution combustion emissions: characterization of causative agents and mechanisms associated with cancer, reproductive, and cardiovascular effects. Mutat Res 2007, 636:95-133.
9. Li D., Wang M., Dhingra K., Hittelman W.N. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res 1996, 56:287-293.
10. Kronenberg S., Esser C., Carlberg C. An aryl hydrocarbon receptor conformation acts as the functional core of nuclear dioxin signaling. Nucleic Acids Res 2000, 28:2286-2291.
11. Safe S. Molecular biology of the Ah receptor and its role in carcinogenesis. Toxicol Lett 2001, 120:1-7.
12. Dertinger S.D., Lantum H.B., Silverstone A.E., Gasiewicz T.A. Effect of 3'-methoxy-4'-nitroflavone on benzo[a]pyrene toxicity. Aryl hydrocarbon receptor-dependent and -independent mechanisms. Biochem Pharmacol 2000, 60:189-196.
13. Shimizu Y., Nakatsuru Y., Ichinose M., Takahashi Y., Kume H., Mimura J., et al. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc Natl Acad Sci USA 2000, 97:779-782.
14. Buters J.T., Sakai S., Richter T., Pineau T., Alexander D.L., Savas U., et al. Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas. Proc Natl Acad Sci USA 1999, 96:1977-1982.
15. Kleiner H.E., Vulimiri S.V., Reed M.J., Uberecken A., DiGiovanni J. Role of cytochrome P450 1a1 and 1b1 in the metabolic activation of 7,12-dimethylbenz[a]anthracene and the effects of naturally occurring furanocoumarins on skin tumor initiation. Chem Res Toxicol 2002, 15:226-235.
16. MacDonald C.J., Ciolino H.P., Yeh G.C. Dibenzoylmethane modulates aryl hydrocarbon receptor function and expression of cytochromes P50 1A1, 1A2, and 1B1. Cancer Res 2001, 61:3919-3924.
17. Fisher M.B., Vandenbranden M., Findlay K., Burchell B., Thummel K.E., Hall S.D., et al. Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank. Pharmacogenetics 2000, 10:727-739.
18. Yueh M.F., Nguyen N., Famourzadeh M., Strassburg C.P., Oda Y., Guengerich F.P., et al. The contribution of UDP-glucuronosyltransferase 1A9 on CYP1A2-mediated genotoxicity by aromatic and heterocyclic amines. Carcinogenesis 2001, 22:943-950.
19. Emi Y., Ikushiro S., Iyanagi T. Xenobiotic responsive element-mediated transcriptional activation in the UDP-glucuronosyltransferase family 1 gene complex. J Biol Chem 1996, 271:3952-3958.
20. Guillemette C., Millikan R.C., Newman B., Housman D.E. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res 2000, 60:950-956.
21. Taioli E., Trachman J., Chen X., Toniolo P., Garte S.J. A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res 1995, 55:3757-3758.
22. Zheng W., Xie D.W., Jin F., Cheng J.R., Dai Q., Wen W.Q., et al. Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2000, 9:147-150.
23. Thompson H.J., Singh M. Rat models of premalignant breast disease. J Mammary Gland Biol Neoplasia 2000, 5:409-420.
24. Richelle M., Bortlik K., Liardet S., Hager C., Lambelet P., Baur M., et al. A food-based formulation provides lycopene with the same bioavailability to humans as that from tomato paste. J Nutr 2002, 132:404-408.
25. Chan H.Y., Leung L.K. A potential protective mechanism of soya isoflavones against 7,12-dimethylbenz[a]anthracene tumour initiation. Br J Nutr 2003, 90:457-465.
26. Wang H., Wang Y., Chen Z.Y., Chan F.L., Leung L.K. Hydroxychalcones exhibit differential effects on XRE transactivation. Toxicology 2005, 207:303-313.
27. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
28. Backlund M., Johansson I., Mkrtchian S., Ingelman-Sundberg M. Signal transduction-mediated activation of the aryl hydrocarbon receptor in rat hepatoma H4IIE cells. J Biol Chem 1997, 272:31755-31763.
29. Kris-Etherton P.M., Hecker K.D., Bonanome A., Coval S.M., Binkoski A.E., Hilpert K.F., et al. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med 2002, 113(suppl 9B):71S-88S.
30. Kim D.J., Takasuka N., Kim J.M., Sekine K., Ota T., Asamoto M., et al. Chemoprevention by lycopene of mouse lung neoplasia after combined initiation treatment with DEN, MNU and DMH. Cancer Lett 1997, 120:15-22.
31. Sharoni Y., Giron E., Rise M., Levy J. Effects of lycopene-enriched tomato oleoresin on 7,12-dimethyl-benz[a]anthracene-induced rat mammary tumors. Cancer Detect Prev 1997, 21:118-123.
32. Gonzalez F.J., Gelboin H.V. Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab Rev 1994, 26:165-183.
33. Chan H.Y., Wang H., Leung L.K. The red clover (Trifolium pratense) isoflavone biochanin A modulates the biotransformation pathways of 7,12-dimethylbenz[a]anthracene. Br J Nutr 2003, 90:87-92.
34. Chan N.L., Wang H., Wang Y., Leung H.Y., Leung L.K. Polycyclic aromatic hydrocarbon-induced CYP1B1 activity is suppressed by perillyl alcohol in MCF-7 cells. Toxicol Appl Pharmacol 2006, 213:98-104.
35. Ciolino H.P., Yeh G.C. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol 1999, 56:760-767.
36. Ciolino H.P., Daschner P.J., Yeh G.C. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem J 1999, 340(Pt 3):715-722.
37. Lee H., Wang H.W., Su H.Y., Hao N.J. The structure-activity relationships of flavonoids as inhibitors of cytochrome P-450 enzymes in rat liver microsomes and the mutagenicity of 2-amino-3-methyl-imidazo[4,5-f]quinoline. Mutagenesis 1994, 9:101-106.
38. Kuno T., Togawa H., Mizutani T. Induction of human UGT1A1 by a complex of dexamethasone-GR dependent on proximal site and independent of PBREM. Mol Biol Rep 2008, 35:361-367.
39. Nagasawa H., Mitamura T., Sakamoto S., Yamamoto K. Effects of lycopene on spontaneous mammary tumour development in SHN virgin mice. Anticancer Res 1995, 15:1173-1178.
40. Nahum A., Hirsch K., Danilenko M., Watts C.K., Prall O.W., Levy J., et al. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes. Oncogene 2001, 20:3428-3436.
41. Karas M., Amir H., Fishman D., Danilenko M., Segal S., Nahum A., et al. Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr Cancer 2000, 36:101-111.
42. Amir H., Karas M., Giat J., Danilenko M., Levy R., Yermiahu T., et al. Lycopene and 1,25-dihydroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells. Nutr Cancer 1999, 33:105-112.
43. Dorgan J.F., Sowell A., Swanson C.A., Potischman N., Miller R., Schussler N., et al. Relationships of serum carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk: results from a prospective study in Columbia, Missouri (United States). Cancer Causes Control 1998, 9:89-97.
44. Gann P.H., Ma J., Giovannucci E., Willett W., Sacks F.M., Hennekens C.H., et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 1999, 59:1225-1230.
45. Giovannucci E. Tomatoes, tomato-based products, lycopene, and prostate cancer: review of the epidemiologic literature. J Natl Cancer Inst 1999, 91:317-331.
46. Greenwald P. Cancer prevention clinical trials. J Clin Oncol 2002, 20(suppl 18):14S-22S.